Barinthus Biotherapeutics plc. (BRNS) Insider Trading -- Recent Executive & Director Transactions
9 insiders reported 11 Form 4 transactions for Barinthus Biotherapeutics plc. (BRNS) over the past 18 months (most recent 2026-09-11). Recent activity: Oxford Science Enterprises plc (Insider) Sell 8.8M shares, Phillips Anne M. (Director) Sell 3,000 shares, Wright Robin (Director) Sell 48,256 shares, Morgon Pierre A. (Director) Sell 10,506 shares, Enright William (Chief Executive Officer) Sell 728,454 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-11 | Oxford Science Enterprises plc | Insider | Sell | 8.8M | $967,755 |
| 2026-09-09 | Phillips Anne M. | Director | Sell | 3,000 | $0 |
| 2026-09-09 | Wright Robin | Director | Sell | 48,256 | $0 |
| 2026-09-09 | Morgon Pierre A. | Director | Sell | 10,506 | $0 |
| 2026-09-09 | Enright William | Chief Executive Officer | Sell | 728,454 | $0 |
| 2026-09-09 | Enright William | Chief Executive Officer | Sell | 514,923 | $0 |
| 2026-09-09 | Hooftman Leon | Chief Medical Officer | Buy | 361,530 | $0 |
| 2026-09-09 | Hooftman Leon | Chief Medical Officer | Sell | 361,530 | $0 |
| 2026-09-09 | DAWES KAREN A | Director | Sell | 1,700 | $0 |
| 2026-09-09 | Scheeren Joseph | Director | Sell | 23,000 | $0 |
| 2026-09-09 | Hammacher Alex | Director | Sell | 3,000 | $0 |
Source: SEC Form 4 filings · as of 2026-09-11